Finally, using spatial transcriptomics, we showed a directionally concordant relationship in the tissue for the protective effects of MSMB, the protein most strongly associated with all three prostate cancer outcomes, by demonstrating lower expression of MSMB in higher grade prostate cancer tumour tissue compared to lower grade and benign regions. This evidence concerns the gene MSMB and prostate carcinoma.